Shares of Telix Pharmaceuticals Limited (TLX) are moving up about 5 percent after the company announced first-quarter financial results, which saw 24% increase in revenue to $230 million from $186 million in the prior year.
The company's shares are currently trading at $9.58 on the Nasdaq, up 5.39 percent. The stock opened at $9.49 and has climbed as high as $9.64 so far in today's session. Over the past year, it has traded in a range of $6.28 to $20.00.
Looking ahead to 2026, Telix reaffirmed its full-year revenue guidance of $950 million to $970 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.